Related Experiment Video
Updated: Jun 28, 2026

Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
Published on: March 17, 2023
[Update on regulatory framework and certification process]
1EFS Alpes-Méditerranée, Marseille, France. dominique.legrand@efs.sante.fr
Patients receiving blood transfusion must benefit from the same quality of care, no matter where they are treated. In an effort to enhance transfusion safety, regulations applicable to blood depot facilities have been considerably reinforced over the last few years. At the present time, facilities authorized to store and distribute labile blood products are subject to the same principles of good practice as transfusion centers. A series of regulations published in 2007 established the duties and responsibilities of depot facilities according to category (emergency, intermediary or distribution) and set out the conditions for certification.
Patients receiving blood transfusion must benefit from the same quality of care, no matter where they are treated. In an effort to enhance transfusion safety, regulations applicable to blood depot facilities have been considerably reinforced over the last few years. At the present time, facilities authorized to store and distribute labile blood products are subject to the same principles of good practice as transfusion centers. A series of regulations published in 2007 established the duties and responsibilities of depot facilities according to category (emergency, intermediary or distribution) and set out the conditions for certification.
Related Concept Videos
Global Regulatory Systems
Drug Regulation
Drug Control Governance: Regulatory Bodies and Their Impact
Good Manufacturing Practices
FDA Approved Drugs: Changes to Approved Drugs
Quality Assurance
